Residual Gastric Content and Perioperative Semaglutide Use Assessed by Gastric Ultrasound: A Prospective Observational Study - databank

In this prospective observational study, 240 patients were grouped according to whether they had received preoperative once-weekly subcutaneous semaglutide within 10 days of the procedure (semaglutide group), and those not exposed to semaglutide (non-semaglutide group). On the day of surgery, all patients underwent preoperative gastric point-of-care ultrasound to evaluate their residual gastric content.